TREATMENT OF SYSTEMIC JUVENILE XANTHOGRANULOMA WITH IL-1 RECEPTOR ANTAGONIST ANAKINRA

被引：0
|
作者：
Akshintala, Srivandana [1 ]
Rossi, Christopher [2 ]
Ladisch, Stephan [1 ]
Greenberg, Jay [1 ]
机构：
[1] Childrens Natl Med Ctr, Dept Hematol Oncol, Washington, DC 20010 USA
[2] Childrens Natl Med Ctr, Dept Pathol, Washington, DC 20010 USA
来源：
PEDIATRIC BLOOD & CANCER | 2013年 / 60卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E70 / E70
页数：1
相关论文
共 50 条
  • [1] Pilot Study of IL-1 Antagonist Anakinra for Treatment of Endometriosis
    Sullender, Renee
    Agarwal, Ravi K.
    Jacobs, Marni B.
    Wessels, Jocelyn M.
    Foster, Warren G.
    Agarwal, Sanjay K.
    INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2024, 16 : 1583 - 1593
  • [2] Recurrent poliserositis succesfully treated with IL-1 receptor antagonist Anakinra
    MS Camacho Lovillo
    E Iglesias
    O Neth
    V Santa-María
    JL Gavilán
    Pediatric Rheumatology, 9 (Suppl 1)
  • [3] Refractory relapsing polychondritis: rapid and sustained response in the treatment with an IL-1 receptor antagonist (anakinra)
    Vounotrypidis, P
    Sakellariou, GT
    Zisopoulos, D
    Berberidis, C
    RHEUMATOLOGY, 2006, 45 (04) : 491 - 492
  • [4] Non-complementaemic urticarial vasculitis: successful treatment with the IL-1 receptor antagonist, anakinra
    Botsios, C.
    Sfriso, P.
    Punzi, L.
    Todesco, S.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2007, 36 (03) : 236 - 237
  • [5] Successful treatment of pyoderma gangrenosum associated with IgA gammopathy with the IL-1 receptor antagonist anakinra
    Rousset, P.
    Dugourd, P. M.
    Lanteri, A.
    Montaudie, H.
    Passeron, T.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2021, 35 (07) : E447 - E450
  • [6] AN IL-1 RECEPTOR ANTAGONIST (ANAKINRA) AS A THERAPEUTIC OPTION FOR TREATMENT-RESISTANT SEIZURES (TRS)
    Rahimian, V.
    Jyonouchi, H.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2011, 107 (05) : A89 - A89
  • [7] ANAKINRA IN THE TREATMENT OF EXTRACUTANEOUS JUVENILE XANTHOGRANULOMA
    McLaughlin, Lauren
    Pecker, Lydia
    Mapombo-Choupa, Sacha
    Guerrera, Michael
    Loechelt, Brett
    Greenberg, Jay
    PEDIATRIC BLOOD & CANCER, 2015, 62 : 62 - 62
  • [8] The efficacy and safety of interleukin-1-receptor antagonist anakinra in the treatment of systemic juvenile idiopathic arthritis
    Swart, Joost Frans
    Barug, Daantje
    Mohlmann, Michelle
    Wulffraat, Nico M.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2010, 10 (12) : 1743 - 1752
  • [9] THE IL-1 RECEPTOR ANTAGONIST ANAKINRA CONTROLS INFECTION AND INFLAMMATION IN CYSTIC FIBROSIS
    Romani, Luigina
    Iannitti, Rossana G.
    OIkonomou, Vasilis
    Pariano, Marilena
    Borghi, Monica
    Puccetti, Matteo
    Galosi, Claudia
    Napolioni, Valerio
    PEDIATRIC PULMONOLOGY, 2016, 51 : 161 - 162
  • [10] Treatment With Anakinra, a Recombinant IL-1 Receptor Antagonist, Unlikely to Induce Lasting Remission in Patients With CGD Colitis
    Hahn, Katherine J.
    Ho, Nancy
    Yockey, Lynne
    Kreuzberg, Samantha
    Daub, Janine
    Rump, Amy
    Marciano, Beatriz E.
    Quezado, Martha
    Malech, Harry L.
    Holland, Steven M.
    Heller, Theo
    Zerbe, Christa S.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 (06) : 938 - 939
12345